Cross-study analyses of the ropeginterferon alfa-2b effect on phlebotomy in low- and high-risk patients with polycythemia vera

V617F allele burden reduction than slow titration. Both regimens were safe and well tolerated. Ropeg treatment provides durable Hct control and phlebotomy-independence in a broad PV population, including high-risk patients.

Authors

Institutions

Publication Details

Journal
Leukemia & lymphoma/Leukemia and lymphoma
Published
2026-07-17
DOI
https://doi.org/10.1080/10428194.2026.2699995
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cross-study analyses of the ropeginterferon alfa-2b effect on phlebotomy in low- and high-risk patients with polycythemia vera

Albert Qin, Anthony M. Hunter, Norio Komatsu, Daoxiang Wu et al.
Leukemia & lymphoma/Leukemia and lymphoma
Myeloproliferative Neoplasms: Diagnosis and Treatment
article

Cross-study analyses of the ropeginterferon alfa-2b effect on phlebotomy in low- and high-risk patients with polycythemia vera

Albert Qin, Anthony M. Hunter, Norio Komatsu, Daoxiang Wu, Abdulraheem Yacoub, Ghaith F. Abu-Zeinah, Kazuya Shimoda, Lucia Masárová, Sung‐Eun Lee, Keita Kirito, Ji Yun Lee, Toshiaki Sato, Han Chiu, Zhang Lei, Ruben Mesa, Yun Lee, Jie Jin
article en

Abstract

V617F allele burden reduction than slow titration. Both regimens were safe and well tolerated. Ropeg treatment provides durable Hct control and phlebotomy-independence in a broad PV population, including high-risk patients.

Leukemia & lymphoma/Leukemia and lymphoma
University of Miyazaki (JP), The University of Texas MD Anderson Cancer Center (US), Emory University (US), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Cornell University (US), Cancer Institute (WIA) (IN), Sinovac Biotech (CN), New Generation University College (ET), Seoul National University Bundang Hospital (KR), Juntendo University (JP), St. Mary's Hospital (US), Levine Cancer Institute (US), National University College (PR), EA Pharma (Japan) (JP), Cellular Therapeutics (United Kingdom) (GB), Institute of Hematology & Blood Diseases Hospital (CN), The Catholic University of Korea Seoul St. Mary's Hospital (KR), First Affiliated Hospital Zhejiang University (CN), Weill Cornell Medicine (US), University of Yamanashi (JP)
Zero hunger
Openalex Percentile: Top 9%
Myeloproliferative Neoplasms: Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.